AgomAb Therapeutics N.V. American Depositary Shares (AGMB) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

AgomAb Therapeutics N.V. American Depositary Shares (AGMB) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $554.0M, listed on NASDAQ, employing roughly 57 people, carrying a beta of 0.00 to the broader market. AgomAb Therapeutics NV, a clinical-stage biopharmaceutical company, develops novel disease-modifying therapies for immunology and inflammatory diseases with a focus on chronic fibrotic indications with unmet medical needs. Led by Tim Knotnerus, public since 2024-05-29.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for AGMB as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →